Evelo Biosciences, Inc. (NASDAQ:EVLO – Get Free Report) was the target of some unusual options trading activity on Wednesday. Investors acquired 1,885 put options on the company. This represents an increase of 1,101% compared to the typical daily volume of 157 put options. Analyst Upgrades and Downgrades Separately, TD Cowen reiterated a “market perform” rating […]
Evelo Biosciences, a biotechnology company launched by Flagship Pioneering to develop microbiome drugs, is shutting down, according to a regulatory filing.…